Stockscreener 앱 받기
24.98
4.28%
1.025
Galecto Inc 주식(GLTO)의 최신 뉴스
Galecto, Inc. (NASDAQ:GLTO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Movement Recap: Is Galecto Incs ROIC above industry averageJuly 2025 Setups & Community Verified Watchlist Alerts - baoquankhu1.vn
Galecto (GLTO) Price Target Increased by 13.89% to 41.82 - Nasdaq
Investment Recap: Can Galecto Inc stock double in next 5 yearsEarnings Recap Report & Safe Entry Point Alerts - Bộ Nội Vụ
Galecto on track to submit IND for mutCALR antibody by mid-2026 - Investing.com Nigeria
Galecto (GLTO) Sets Ambitious Clinical Milestones for 2026 - GuruFocus
Galecto Showcases New mutCALR MPN Pipeline at JPM - TipRanks
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones - The Manila Times
Galecto, Inc. Reports Strategic Shift and Financial Results - MSN
Galecto Completes Acquisition of Damora Therapeutics - MSN
Galecto (NASDAQ:GLTO) Upgraded at Leerink Partnrs - Defense World
What risks investors should watch in Galecto Inc. stock2025 Year in Review & Consistent Growth Equity Picks - ulpravda.ru
Is Galecto Inc. stock attractive for hedge fundsJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Is Galecto Inc. stock supported by innovation pipeline2025 Risk Factors & Fast Gain Swing Alerts - ulpravda.ru
Should I hold or sell Galecto Inc. stock in 2025July 2025 Patterns & High Conviction Investment Ideas - ulpravda.ru
Galecto (NASDAQ:GLTO) Now Covered by Leerink Partners - Defense World
Leerink Partners Initiates Coverage of Galecto (GLTO) with Outperform Recommendation - Nasdaq
Leerink Partners Initiates Coverage on GLTO with 'Outperform' Ra - GuruFocus
Leerink Partners initiates coverage on Galecto stock with Outperform rating By Investing.com - Investing.com Australia
Leerink Partners initiates coverage on Galecto stock with Outperform rating - Investing.com
Galecto strengthens its leadership after recent acquisition in the US - medwatch.com
Galecto appoints former Blueprint Medicines executives as COO and CMO - MSN
Galecto Appoints Sherwin Sattarzadeh as Chief Operating Officer - marketscreener.com
Galecto appoints new chief operating officer, enhances leadership - TipRanks
Galecto announces key additions to leadership team - marketscreener.com
Galecto appoints Sherwin Sattarzadeh as chief operating officer and issues warrant - Investing.com
Galecto, Inc. Appoints New Chief Operating Officer - TradingView — Track All Markets
Galecto Announces Key Additions to Leadership Team - The Manila Times
Galecto (GLTO) grants large warrant and hires new Chief Operating Officer - Stock Titan
Galecto, Inc. Appoints Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer, Effective January 5, 2026 - marketscreener.com
Comparing Galecto (NASDAQ:GLTO) and Avidity Biosciences (NASDAQ:RNA) - Defense World
Is the Market Bullish or Bearish on Galecto Inc? - Benzinga
Will Galecto Inc stock pay special dividends2025 Historical Comparison & Growth-Oriented Investment Plans - Bộ Nội Vụ
Galecto Files to Register 60.5 Million Shares for Secondary Offering - marketscreener.com
GLTO SEC FilingsGalecto Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Galecto (NASDAQ:GLTO) Shares Down 13.3%Time to Sell? - MarketBeat
Galecto (NASDAQ:GLTO) Shares Down 13.3% – Time to Sell? - Defense World
[EFFECT] Galecto, Inc. SEC Filing - Stock Titan
Ideas Watch: Should I hold or sell Galecto Inc stock in 2025 - Bộ Nội Vụ
Why Galecto Inc. stock could benefit from AI revolution2025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - Улправда
Galecto (GLTO) Price Target Increased by 12.50% to 36.72 - Nasdaq
How Galecto Inc. stock performs after earningsQuarterly Profit Summary & Reliable Breakout Forecasts - Улправда
How rising interest rates impact Galecto Inc. stock2025 Winners & Losers & Reliable Trade Execution Plans - DonanımHaber
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Galecto, Inc. announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire Inc.
Galecto (NASDAQ:GLTO) Price Target Raised to $36.00 at Guggenheim - Defense World
Guggenheim Maintains Galecto (GLTO) Buy Recommendation - Nasdaq
Guggenheim raises Galecto stock price target to $36 on positive ASH25 data - Investing.com Nigeria
Galecto (GLTO) Rating Maintained by Guggenheim, Price Target Rai - GuruFocus
4.73%
0.92%
자본화:
|
볼륨(24시간):